22nd Century Group, Inc.

The company is headquartered in the United States and primarily serves U.S.-based customers across its contract manufacturing and branded tobacco activities. Reported volumes indicate that some cigarette production is sold to a U.S. customer for export, making results partially sensitive to export mix and related pricing. Manufacturing is vertically integrated, implying internal control over key production steps for both company-branded products and CMO output. Because the filings provided do not include an authoritative revenue-by-geography table, a quantified regional revenue split is not presented here. Geographic exposure matters mainly through U.S. tobacco regulation (FDA/MRTP), domestic retail/distribution execution for VLN®, and export-driven mix shifts within CMO volumes.

A central company-specific risk is dependence on a small number of contract manufacturing customers, where contract terms (including consideration payable and stepped pricing) can reduce reported revenue and compress margins even when volumes rise. Regulatory risk is structurally high given the FDA’s role in tobacco oversight; while MRTP authorization supports VLN®, changes in regulatory standards, marketing restrictions, or enforcement could impair commercialization. Liquidity risk is elevated because the company has a history of significant losses and negative operating cash flow, increasing reliance on external financing and potentially dilutive securities. Operational risks include manufacturing execution, quality control, and agricultural/leaf supply variability that can disrupt production or raise costs. Industry risks include excise tax changes, litigation exposure typical to tobacco, and demand elasticity that can shift volumes across cigarettes, cigars, and reduced-nicotine alternatives.